Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial.

MLA

Benedetti, Fabrizio, et al. “Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial.” Arthritis & Rheumatology, vol. 67, no. 3, Mar. 2015, pp. 840–48. EBSCOhost, https://doi.org/10.1002/art.38984.

APA

Benedetti, F., Brunner, H., Ruperto, N., Schneider, R., Xavier, R., Allen, R., Brown, D. E., Chaitow, J., Pardeo, M., Espada, G., Gerloni, V., Myones, B. L., Frane, J. W., Wang, J., Lipman, T. H., Bharucha, K. N., Martini, A., & Lovell, D. (2015). Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial. Arthritis & Rheumatology, 67(3), 840–848. https://doi.org/10.1002/art.38984

Chicago

Benedetti, Fabrizio, Hermine Brunner, Nicolino Ruperto, Rayfel Schneider, Ricardo Xavier, Roger Allen, Diane E. Brown, et al. 2015. “Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial.” Arthritis & Rheumatology 67 (3): 840–48. doi:10.1002/art.38984.